Is hormone therapy used for Prostate Cancer and how does it work

Hormone Therapy for Prostate Cancer: How It Works

Yes, hormone therapy is a primary treatment for prostate cancer, especially for advanced stages. Let me explain how it works and why doctors use it.

Why Hormone Therapy Targets Testosterone

Prostate cancer cells typically depend on male hormones called androgens (primarily testosterone) to grow and survive. According to the NCCN Guidelines for Prostate Cancer, the main strategy is called Androgen Deprivation Therapy (ADT) — essentially "starving" the cancer of the hormones it needs to fuel its growth.

Think of it this way: testosterone acts like a messenger telling prostate cancer cells to grow and divide. By reducing testosterone to very low levels, doctors can slow or shrink the tumor.

How Hormone Therapy Works: The Main Approaches

STEP 1: LHRH Agonists and Antagonists

These drugs work on the pituitary gland (in your brain) to stop your testicles from producing testosterone:

• LHRH agonists (leuprolide/Lupron, goserelin/Zoladex, triptorelin/Trelstar) — given as injections monthly or every 2-4 times per year
• LHRH antagonists (degarelix/Firmagon, relugolix/Orgovyx) — relugolix is a daily pill; others are injections

STEP 2: Anti-Androgens (Androgen Receptor Blockers)

These pills block cancer cells from using testosterone even if it's present:

• Bicalutamide, flutamide, nilutamide (older drugs)
• Newer, more effective options: apalutamide (Erleada), darolutamide (Nubeqa), enzalutamide (Xtandi)

STEP 3: Androgen Synthesis Inhibitors

These drugs block your body from making testosterone in the first place:

• Abiraterone (Zytiga) — blocks testosterone production
• Ketoconazole

Treatment Approaches: What Your Doctor Might Recommend

According to NCCN Guidelines, the standard approach has changed significantly:

For Hormone-Sensitive Metastatic Prostate Cancer (cancer that still responds to hormone therapy):

• Preferred approach: ADT combined with a second hormone-reducing medicine (abiraterone, apalutamide, or enzalutamide)
• Research shows patients live longer on combination therapy than ADT alone
• For patients with high-volume cancer (extensive spread), doctors may add chemotherapy (docetaxel) — called "triplet therapy"

For Early-Stage Prostate Cancer:

• Hormone therapy may be given before, during, or after radiation therapy to increase effectiveness
• Often used as short-term treatment (6-36 months depending on risk factors)

Important: Hormone Resistance

Over time, some prostate cancers learn to survive without much testosterone — this is called hormone-resistant prostate cancer (also called castration-resistant prostate cancer). The good news: this is still treatable. Doctors typically keep patients on ADT while adding other treatments like chemotherapy, targeted therapy, or immunotherapy.

Significant Side Effects to Know About

Hormone therapy can have meaningful side effects, especially with longer-term use. According to NCCN Guidelines, these include:

• Sexual side effects: Loss of sex drive, erectile dysfunction (these often improve after stopping treatment)
• Bone health: Thinning and weakening of bones (osteoporosis), increased fracture risk
• Metabolic effects: Weight gain, loss of muscle mass, increased diabetes risk
• Cardiovascular: Increased risk of heart disease and high blood pressure
• Other: Hot flashes, fatigue, mood changes, breast tenderness
• Important note: In Black patients, hormone therapy may increase the risk of death from heart issues

Your care team can help manage these side effects with supportive care, bone-strengthening medications, exercise, and diet changes.

Questions to Ask Your Oncologist

1. Is hormone therapy recommended for my specific stage and type of prostate cancer?
2. Which hormone therapy approach do you recommend, and why?
3. Will I be on ADT alone, or combined with other treatments?
4. How long do you expect I'll need hormone therapy?
5. What side effects should I monitor for, and how can we manage them?
6. How will we measure if the treatment is working? (PSA levels, scans, etc.)
7. What happens if my cancer becomes hormone-resistant?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.